Post-Market Pharmacovigilance and Product Recall: What ASEAN Importers Should Expect from a Taiwan Supply Partner

Why Post-Market Responsibility Matters

Successful registration and delivery represent the beginning of a product's commercial life, not the end of the supply relationship's quality obligations. Once a product reaches hospitals, pharmacies, or distributors in an ASEAN market, ongoing pharmacovigilance and complaint-handling systems become the primary safeguard against quality or safety issues going unnoticed.

Importers evaluating a Taiwan supply partnership should understand what happens after the shipment arrives — not just how it was manufactured and delivered.

Adverse Event and Quality Complaint Reporting

A properly structured supply relationship should include a clear process for:

• →Receiving reports: A defined contact point for hospitals, pharmacies, or distributors to report suspected adverse events or product quality concerns
• →Timely escalation: Reports forwarded to the manufacturer within a defined timeframe for investigation
• →Documentation: A written record of each report, investigation outcome, and any corrective action taken

Importers should confirm this reporting chain exists and functions in practice — not only that it is described in a quality agreement.

Handling Quality Complaints

Quality complaints — such as packaging defects, discoloration, or suspected counterfeit products — require a defined investigation process:

• →Batch retention samples at the manufacturer allow direct comparison against the complaint sample
• →Root cause investigation determines whether the issue is isolated or affects the broader batch
• →Findings and corrective actions should be communicated back to the importer within a reasonable timeframe

Product Recall Procedures

While uncommon, recalls do occur — whether initiated by a regulatory authority, the manufacturer, or the importer upon discovering a quality issue. A well-prepared supply partnership should have clarity on:

• →Recall classification: Understanding whether an issue warrants a full market recall or a more limited corrective action
• →Traceability: The ability to trace affected batches through the distribution chain back to specific customers or facilities
• →Communication protocol: A defined process for notifying affected customers and the relevant regulatory authority
• →Responsibility allocation: Clarity on which party — manufacturer, distributor, or importer — leads each step of the recall process

The ability to trace a specific batch quickly through the entire supply chain depends on the traceability and documentation practices already established during distribution — reinforcing why documented batch traceability throughout storage and transport is not just a registration requirement, but an ongoing safety capability.

What Importers Should Confirm Before Committing to a Supply Partnership

• →Is there a designated contact for adverse event and quality complaint reporting, and what is the expected response time?
• →Does the manufacturer maintain batch retention samples for complaint investigation?
• →Is there a documented recall procedure, and has it been tested or exercised previously?
• →How is responsibility divided between manufacturer, distributor, and importer during a recall event?

Summary

A supply relationship that ends at delivery leaves importers exposed if a quality or safety issue emerges later. Confirming that a Taiwan supply partner maintains structured pharmacovigilance reporting, complaint investigation, and recall procedures — not just manufacturing and export capability — provides a more complete picture of long-term supply chain reliability.